Sun Pharma has received final approval from the USFDA to make and sell generic Alendronate Sodium tablets, 5 mg, 10 mg, 35 mg and 70 mg.
Alendronate Sodium tablets are the generic version of Merck’s Fosamax tablets, which are indicated for the treatment and prevention of osteoporosis in post menopausal women.
These strengths of Fosamax tablets have annual sales of about $560 million in the U.S.
The company said these products will reach the market shortly.
Alendronate Sodium tablets are the generic version of Merck’s Fosamax tablets, which are indicated for the treatment and prevention of osteoporosis in post menopausal women.
These strengths of Fosamax tablets have annual sales of about $560 million in the U.S.
The company said these products will reach the market shortly.
No comments:
Post a Comment